Onvansertib (NMS-P937)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
1034616-18-6
PCM-075, NMS1286937
C12551-10mg
PLK
Cell Cycle
CN1CCN (CC1) C2=CC (=C (C=C2) OC (F) (F) F) NC3=NC=C4CCC5=C (C4=N3) N (N=C5C (=O) N) CCO
C24H27F3N8O3
Onvansertib (NMS-P937, PCM-075, NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Onvansertib (NMS-P937) potently causes a mitotic cell-cycle arrest followed by apoptosis in cancer cell lines and inhibits tumor growth. Phase 1.
2 years -80 in solvent
Beschrijving
Onvansertib (NMS-P937) Beschikbaar in 10 mg. Wordt geleverd met droogijs. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
AffiniPure Goat Anti-Rabbit IgG H&L, HRP conjugated
GTR17765564-01
100 µL
Pribolab® Automatic Immunoaffinity Column Purification System
HWEQ-IM 5050
1 Unit
OneTaq Hot Start 2X Master Mix with GC Buffer
NEB M0485L
500 Reactions
HyperLadder 1kb
BIO-33053
100 Lanes
MicroMolar UDP assay kit - 100 assays
MUD100K
100 Assays
MEM Amino Acids Solution (50x) w/o: L-Glutamine
P08-30100
100 mL
White glass slide, frosted
1380-20
1440/CS
Anti-TNF-α (Adalimumab), humanized Antibody
A1048-100
100 µg